C69.82
BillableMalignant neoplasm of overlapping sites of left eye and adnexa
Last updated: FY2026 ICD-10-CM (Oct 1, 2025 – Sep 30, 2026) | CMS-HCC V28 (100% phase-in, PY2026)
Is C69.82 an HCC code?
Yes. C69.82 maps to Melanoma and Other Skin Cancers under the CMS-HCC V28 risk adjustment model (and Breast, Prostate, and Other Cancers and Tumors under V24).
HCC Category Mapping
RAF weights shown are the community, non-dual, aged base weights from the CMS risk adjustment model file. Actual per-patient RAF contribution depends on member segment, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains in use during the transition and for historical data.
MEAT Criteria for C69.82
For C69.82 to count as a valid HCC diagnosis in a given encounter, the provider's documentation must show MEAT: Monitor, Evaluate, Assess, or Treat. A diagnosis from a prior year does not carry forward automatically — it has to be re-documented and supported each calendar year.
- MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
- EEvaluate: test results, medication response, or physical findings reviewed by the provider
- AAssess: explicit mention in the assessment or plan with acknowledgment of status
- TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis
Only one of M/E/A/T is required to support the code, but the documentation must be specific enough to show that the provider actually addressed C69.82 during that encounter — not just copy-forwarded from a problem list.
What This Code Means
C69.82 is the ICD-10-CM diagnosis code for malignant neoplasm of overlapping sites of left eye and adnexa. Cancer involving multiple overlapping structures of the left eye and surrounding tissues. C69.82 sits in the ICD-10-CM chapter for neoplasms (c00-d49), within the section covering malignant neoplasms of eye, brain and other parts of central nervous system (c69-c72).
Under the CMS-HCC V28 risk adjustment model, C69.82 maps to Melanoma and Other Skin Cancers (HCC 23) with a community, non-dual, aged base RAF weight of 0.251. Under the older CMS-HCC V24 model, C69.82 maps to Breast, Prostate, and Other Cancers and Tumors (HCC 12) with a community, non-dual, aged base RAF weight of 0.150. V28 is the CMS-HCC risk adjustment model that reached 100% phase-in for payment year 2026, replacing V24 which was used during the PY2024–PY2025 transition.
Confirm left side and overlapping sites are documented. Because C69.82 maps to a payment HCC, the provider's documentation must satisfy MEAT criteria (Monitor, Evaluate, Assess, or Treat) for the encounter to count toward the patient's Medicare Advantage risk adjustment score. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.
HCC Buddy maintains structured V28 and V24 mapping, RAF weights, and MEAT documentation criteria for C69.82 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.
Coding Tips
- •Confirm left side and overlapping sites are documented
- •Review pathology to identify all involved anatomical structures
Clinical Significance
Left eye and adnexa overlapping malignancy represents advanced multi-structure ocular cancer requiring aggressive treatment. Accurate laterality coding is a patient safety priority to prevent wrong-side surgical interventions, particularly when orbital exenteration is planned.
Documentation Requirements
- ✓Pathology confirming malignancy involving multiple left eye/adnexal structures
- ✓Explicit documentation of left side involvement
- ✓Detailed imaging of all involved structures
- ✓Assessment of the extent of disease for treatment planning
- ✓Documentation of visual function status
Commonly Confused Codes
- •C69.81 — Right eye overlapping sites: verify laterality carefully
- •C69.62 — Left orbit only: use overlapping code when eye structures beyond the orbit are involved
- •C69.80 — Unspecified eye overlapping sites: use C69.82 when left side is documented
- •C69.92 — Unspecified site of left eye: use overlapping code when multiple specific sites are involved